Real-life impacts of olipudase alfa: The experience of patients and families taking an enzyme replacement therapy for acid sphingomyelinase deficiency.

Raebel EM, Wiseman S, Donnelly C, Mathieson T, Pountney J, Crowe J, Hopkin J.

Open source

DOI
10.1186/s13023-024-03020-4
Published
2024-02-01
Container
Orphanet J Rare Dis
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13023-024-03020-4,
  title = {Real-life impacts of olipudase alfa: The experience of patients and families taking an enzyme replacement therapy for acid sphingomyelinase deficiency.},
  author = {Raebel EM and  Wiseman S and  Donnelly C and  Mathieson T and  Pountney J and  Crowe J and  Hopkin J.},
  year = {2024},
  journal = {Orphanet J Rare Dis},
  doi = {10.1186/s13023-024-03020-4},
  url = {https://doi.org/10.1186/s13023-024-03020-4}
}

RIS

TY  - JOUR
TI  - Real-life impacts of olipudase alfa: The experience of patients and families taking an enzyme replacement therapy for acid sphingomyelinase deficiency.
AU  - Raebel EM
AU  -  Wiseman S
AU  -  Donnelly C
AU  -  Mathieson T
AU  -  Pountney J
AU  -  Crowe J
AU  -  Hopkin J.
PY  - 2024
JO  - Orphanet J Rare Dis
DO  - 10.1186/s13023-024-03020-4
UR  - https://doi.org/10.1186/s13023-024-03020-4
ER  - 

APA

EM, R., S, W., C, D., T, M., J, P., J, C., & J., H. (2024). Real-life impacts of olipudase alfa: The experience of patients and families taking an enzyme replacement therapy for acid sphingomyelinase deficiency.. Orphanet J Rare Dis. https://doi.org/10.1186/s13023-024-03020-4

Source records